Literature DB >> 22747548

Non-analgesic effects of opioids: interactions between opioids and other drugs.

Tarja Heiskanen1, Eija Kalso.   

Abstract

Opioids are increasingly used to manage not only acute but also chronic pain and heroine addiction. These patients usually receive many other medications that can interfere with the effects of opioids and vice versa. Patients often need combinations of drugs for their pain management, for treating opioid-related adverse effects or for other indications including depression and anxiety. Several antibiotics can also have interactions with opioids. It is important to understand what potential interactions exist between opioids and other drugs. Drug interactions can occur due to pharmacokinetic interactions including effects of absorption, metabolic pathways, drug transport through membranes and protein binding. Our knowledge of the metabolism of opioids has significantly increased over the last years and it is now possible to appreciate the role CYP enzymes, mainly CYP 2D6 and 3A4/5, in the metabolism of many commonly used opioids like codeine and oxycodone. Our knowledge regarding the role of the transporter proteins in drug interactions related to opioids is unfortunately meagre. Opioids inhibit the gastrointestinal system and can thus change the absorption of other drugs. Opioids can have synergistic or additive interactions with other drugs that have analgesic or sedative effects. Endogenous opioids control many physiological functions and exogenous opioids can have effects on all important transmitter systems (cholinergic, GABAergic, dopaminergic and serotonergic). The literature in this field is mainly based on case reports. Interindividual differences play an important role. Other potential interactions include prolongation of the QT-interval and lowering of the threshold for convulsions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22747548     DOI: 10.2174/138161212803582423

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Changes in brain oxygen and glucose induced by oxycodone: Relationships with brain temperature and peripheral vascular tone.

Authors:  Ernesto Solis; Anum Afzal; Eugene A Kiyatkin
Journal:  Neuropharmacology       Date:  2018-02-21       Impact factor: 5.250

2.  The grass is not always greener: a multi-institutional pilot study of marijuana use and acute pain management following traumatic injury.

Authors:  Kristin Salottolo; Laura Peck; Allen Tanner Ii; Matthew M Carrick; Robert Madayag; Emmett McGuire; David Bar-Or
Journal:  Patient Saf Surg       Date:  2018-06-19

3.  Acute pain management among patients with opioid maintenance therapy: specificities and difficulties identified in primary care: a qualitative study.

Authors:  Morgane Guillou Landreat; Melia Baillot; Delphine Le Goff; Jean Yves Le Reste
Journal:  BMJ Open       Date:  2021-01-19       Impact factor: 2.692

4.  Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers.

Authors:  Terhi J Lohela; Satu Poikola; Mikko Neuvonen; Mikko Niemi; Janne T Backman; Klaus T Olkkola; Tuomas O Lilius
Journal:  Anesth Analg       Date:  2021-08-01       Impact factor: 6.627

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.